Starpharma Holdings Ltd. revenue for the last year amounted to 2.70 M USD, the most of which — 1.98 M USD — came from its highest performing source at the moment, Dendrimers, the year earlier bringing 3.40 M USD. The greatest contribution to the revenue figure was made by Australia — last year it brought Starpharma Holdings Ltd. 1.98 M USD, and the year before that — 3.40 M USD.